Context Therapeutics Inc. Quarterly Return On Assets in % from Q2 2022 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Context Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from Q2 2022 to Q2 2024.
  • Context Therapeutics Inc. Return On Assets for the quarter ending June 30, 2024 was -48.6 %, a 9.33% increase year-over-year.
  • Context Therapeutics Inc. annual Return On Assets for 2023 was -97 %, a 181% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -48.6 +5 +9.33% Apr 1, 2024 Jun 30, 2024
Q1 2024 -110 -64.4 -142% Jan 1, 2024 Mar 31, 2024
Q4 2023 -97 -62.5 -181% Oct 1, 2023 Dec 31, 2023
Q3 2023 -68.8 -37.7 -122% Jul 1, 2023 Sep 30, 2023
Q2 2023 -53.6 -20.7 -62.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -45.2 Jan 1, 2023 Mar 31, 2023
Q4 2022 -34.6 Oct 1, 2022 Dec 31, 2022
Q3 2022 -31.1 Jul 1, 2022 Sep 30, 2022
Q2 2022 -32.9 Apr 1, 2022 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.